<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01975545</url>
  </required_header>
  <id_info>
    <org_study_id>MCIC-001</org_study_id>
    <nct_id>NCT01975545</nct_id>
  </id_info>
  <brief_title>Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21</brief_title>
  <official_title>Efficacy of the Addition of Silver Nanoparticles to a Fluor Varnish in the Remineralization of Temporary Teeth in Patients With Trisomy 21. Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de San Luis Potosí</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Autonoma de San Luis Potosí</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with trisomy 21 are in greater danger of developing caries. It has been hypothesized
      that adding silver nanoparticles to fluor varnishes could promote remineralization of the
      teeth. A split-plot randomized controlled trial will be performed to address this question.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remineralization</measure>
    <time_frame>3 months</time_frame>
    <description>Remineralization status will be assessed through laser fluorescence of the tooth with a Diagnodent probe (Diagnodent, Kavo, Madrid, Spain)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Down Syndrome</condition>
  <arm_group>
    <arm_group_label>Fluor varnish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluor varnish with nanoparticles</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluor dental varnish (Fluor Protector, Ivoclar Vivadent, Principality of Liechtenstein) plus 25% 50 nm silver nanoparticles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluor varnish</intervention_name>
    <description>Dental varnish will be applied to one anterior superior teeth in a random side.</description>
    <arm_group_label>Fluor varnish</arm_group_label>
    <other_name>Fluor dental varnish</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluor varnish with nanoparticles</intervention_name>
    <description>Dental varnish with silver nanoparticles will be applied to one anterior superior teeth in a random side.</description>
    <arm_group_label>Fluor varnish with nanoparticles</arm_group_label>
    <other_name>Fluor dental varnish with silver nanoparticles.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with trisomy 21 diagnosed through caryotype

          -  Age 1 to 6 years old

          -  Any sex

          -  White spot present in both upper anterior teeth

          -  Parental agreement to participate in the study

        Exclusion Criteria:

          -  Hypersensibility to any of the substances used

          -  Non cooperating patients

          -  Caries in enamel or dentine in the upper anterior teeth

          -  Leukemia or diabetes

          -  Dental fluorosis present
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mauricio Pierdant-Pérez, Md, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Autónoma de San Luis Potosí</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Autónoma de San Luis Potosí</name>
      <address>
        <city>San Luis Potosí</city>
        <zip>78210</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2013</study_first_submitted>
  <study_first_submitted_qc>October 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2013</study_first_posted>
  <last_update_submitted>March 5, 2014</last_update_submitted>
  <last_update_submitted_qc>March 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de San Luis Potosí</investigator_affiliation>
    <investigator_full_name>Claudia Butrón Téllez Girón</investigator_full_name>
    <investigator_title>Claudia Butrón-TéllezGiron, Dent.</investigator_title>
  </responsible_party>
  <keyword>Down syndrome</keyword>
  <keyword>Caries</keyword>
  <keyword>Dental varnish</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Trisomy</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 25, 2014</submitted>
    <returned>April 25, 2014</returned>
    <submitted>December 16, 2014</submitted>
    <returned>December 27, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

